The ERAS Society has published evidence-based guidelines for more than 30 surgical specialties. Each guideline reviewed the literature, scored evidence quality, and produced specialty-specific protocols. The dose-response relationship is consistent across specialties: higher protocol compliance is associated with fewer complications and shorter length of stay. Dr. Khaled Ghalwash and Dr. Mohamed Ghalwash apply the relevant specialty guideline to every elective procedure.
The strongest evidence is in colorectal surgery, where ERAS originated and the most randomized data exists. The principles transfer to other specialties with documented benefit. The table and detail below summarise outcomes specialty by specialty.
| Specialty | Documented benefit | Key reference |
|---|---|---|
| Colorectal surgery | Up to 50% complication reduction; 42% improved 5-year cancer survival; 30-50% LOS reduction | Varadhan 2010 meta-analysis; Gustafsson 2011/2016 |
| Bariatric surgery | Reduced LOS, fewer complications, faster recovery in sleeve gastrectomy and gastric bypass | Stenberg et al. 2021 ERAS Society guidelines |
| Liver surgery | Significantly reduced overall morbidity, accelerated functional recovery, decreased LOS | Hughes 2014 meta-analysis |
| Pancreatic cancer surgery | >80% protocol compliance associated with significant mortality reduction, fewer major complications, shorter LOS | Kagedan 2015; Wijk et al. multi-center |
| Gastric cancer surgery | Reduced LOS and complications | Mortensen et al. 2014 ERAS guidelines |
| Esophageal cancer surgery | Reduced pulmonary complications and LOS | Low et al. 2019 ERAS guidelines |
| Gynecologic oncology | Reduced LOS, complications, and opioid use | Nelson et al. 2016/2019/2023 |
| Breast reconstruction | Reduced LOS and opioid use; faster return to normal activity | Temple-Oberle et al. 2017 |
| Head and neck cancer | Reduced complications and LOS | Dort et al. 2017 |
| Cardiac surgery | Reduced ICU LOS and complications | Engelman et al. 2019 |
| Lung surgery | Reduced pulmonary complications and LOS | Batchelor et al. 2019 |
| Hip and knee replacement | Reduced LOS and opioid use; equivalent or better functional outcomes | Wainwright et al. 2020 |
| Spine surgery | Reduced LOS and opioid use; faster mobilisation | Debono et al. 2021 |
| Cesarean delivery | Reduced LOS, opioid use, post-op nausea | Wilson et al. 2018; Caughey 2018; Macones 2019 |
| Emergency laparotomy | Reduced mortality and LOS even in emergency setting | Peden et al. 2021/2023 |
Dr. Khaled Ghalwash applies the ERAS Society guideline that matches each operation. The bariatric protocol differs from the colorectal protocol differs from the gallbladder protocol. The principles are common: reduce stress, restore function fast. The specifics are tailored. There is no surgery in this practice that does not get the relevant ERAS guideline.
ERAS is not all-or-nothing. The benefit scales with compliance. Wijk et al. studied over 2,000 patients across 10 international centres and found that every unit increase in ERAS guideline score was associated with an 8 to 12 percent decrease in days in hospital. The implication is concrete: even partial compliance helps; full compliance helps more.
This is why audit and continuous protocol improvement are part of the ERAS framework. We measure which elements of the protocol were delivered to each patient and feed that back to the team. Most units find on first audit that they were wrong about their own practice. Reality differs from intention until measured.
Dr. Khaled Ghalwash and Dr. Mohamed Ghalwash perform a range of operations. ERAS application by surgery:
Yes, this is where ERAS has the strongest evidence. Meta-analysis of randomized trials shows complications reduced by up to 50% when ERAS principles are followed. A 5-year follow-up of nearly 1000 patients found 42% improved survival in cancer surgery with high ERAS compliance.
Yes. The 2021 ERAS Society bariatric guideline (update of 2016) is in active use globally. Outcomes favor ERAS in length of stay, complications, and patient-reported recovery for sleeve gastrectomy and gastric bypass.
Yes for colorectal, liver, pancreatic, gastric, esophageal, gynecologic, head and neck, lung, and bladder cancer surgery. Better compliance is associated with reduced mortality and length of stay. For pancreatic cancer specifically, >80% protocol compliance was associated with significant mortality reduction.
Yes. The first ERAS case series was specifically in elderly patients (ages 71-88) and showed faster recovery than traditional care. Frailty and comorbidities are reasons to USE ERAS, not to avoid it.
Yes. The ERAS Society has published guidelines specifically for low- and middle-income countries (Oodit et al. 2022). The principles work regardless of resource level: minimal kit is needed, the gains come from changing protocols not buying technology.
Yes. The ERAS protocol works very well for open surgery. The combination of ERAS + minimally invasive surgery gives the best results, but ERAS alone significantly improves open-surgery outcomes.
Yes. Per-patient cost savings range from $1,000 to $8,700 depending on country and procedure. Hospital return-on-investment ratios for implementation programs are 3.8 to 7.3 (Alberta, Canada data). The savings come from reduced length of stay, fewer complications, and fewer readmissions.
Book your pre-operative consultation. We walk you through the ERAS protocol that applies specifically to your surgery, including the expected length of stay, recovery milestones, and discharge criteria.
WhatsApp 01500509000